Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Enable Injections Announces Regulatory Approval in Saudi Arabia for the EMPAVELI® Injector based on enFuse® Technology
-
Terra Innovatum Global Honored with Sustainability Special Mention at 2025 UNCA Awards
-
Issue of Supplementary Prospectus
-
Schouw & Co.’s financial calendar 2026
-
Kane Biotech Announces Closing of Private Placement Offering with an Insider of the Company
-
CTO Realty Growth Announces Acquisition of Pompano Citi Centre for $65.2 Million
-
Regenx Receives Funding Support to Advance Proprietary Technology
-
Inno Holdings Inc. Announces 1-for-24 Reverse Stock Split as Part of Strategic Nasdaq Compliance Initiative
-
Man Group PLC : Form 8.3 - Dowlais Group plc
-
Man Group PLC : Form 8.3 - American Axle & Manufacturing Holdings, Inc
-
Yacht Club de Monaco closes the 2025 season with the YCM Awards
-
Schouw & Co. to initiate share buy-back programme of up to DKK 240 million
-
Man Group PLC : Form 8.3 - Unite Group plc
-
CAMP4 Announces Pricing of $30.0 Million Underwritten Offering of Common Stock
-
Dimensional Fund Advisors Ltd. : Form 8.3 - JUST GROUP PLC - Ordinary Shares
-
Dimensional Fund Advisors Ltd. : Form 8.3 - INTERNATIONAL PERSONAL FINAN - Ordinary Shares
-
NRx Pharmaceuticals (Nasdaq:NRXP) announces elimination of all balance sheet debt following equity conversion
-
Athira Pharma Announces Exclusive License to Lasofoxifene Phase 3 Development Program for Metastatic Breast Cancer Candidate and a Financing for up to $236 Million
-
Anfield Energy Announces Agreement to Acquire BRS Engineering, Bolstering In-House Technical Expertise for Uranium and Vanadium Projects
-
Apollo Silver Secures 100% Interest in Athena Claims at Langtry
-
Celebrate the season island-style: King’s Hawaiian hosts holiday happy hour pop-up in Toronto
-
Aya Gold & Silver Files Preliminary Economic Assessment Technical Report for Boumadine Project
-
Avadel Pharmaceuticals Announces Completion of Enrollment in Phase 3 REVITALYZ™ Trial in Idiopathic Hypersomnia
-
Kamada Announces a $10-$14 Million Extension of Canadian Supply Tender
-
Atavistik Bio Raises $120 Million Series B Financing to Advance the Development of Selective Allosteric Small Molecule Therapeutics for the Treatment of Hereditary Hemorrhagic Telangiectasia (HHT) and
-
BioStem Technologies Products Placed on “12-Month Status Quo Period” List in Update to CMS CY 2026 Final Medicare Reimbursement Rule for Skin Substitutes
-
Mutuum Finance (MUTM) Strengthens Security Framework with CertiK Review and Active Halborn Audit
-
Hydreight Exceeds 1.3 Million Product Orders Placed, Surpassing 2025 Operational Targets
-
Sagimet Biosciences Announces Positive Results from the Phase 1 PK Clinical Trial of Denifanstat and Resmetirom Combination
-
Talisker Provides Update on Staff Reduction at Bralorne due to Atmospheric River Event in Southern British Columbia
-
Nasdaq Maintains Over a Decade of Listings Leadership in 2025
-
Gain Therapeutics Announces Positive Results in Key Exploratory Endpoint from its Phase 1b Clinical Study of GT-02287 in People with Parkinson’s Disease
-
Rapport Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference
-
Lifecore Biomedical to be Added to Nasdaq Biotech Index
-
Perspective Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference
-
Nutriband Differentiates Prescription Fentanyl from Illicit Fentanyl in Response to United States Executive Order Designating Fentanyl as a Weapon of Mass Destruction
-
BitMart Launches Christmas Mega Giveaway with Over 1,000,000 USDT in Rewards
-
ONAR Holding Corporation Retires $311,000 in Debt Through Equity Conversion, Strengthens Balance Sheet, and Aligns Long-Term Partners with Shareholders
-
CAMP4 and GSK Enter Strategic Collaboration to Advance RNA-Based Therapeutic Discoveries
-
Pyxis Oncology Announces Positive Preliminary Phase 1 Data for Micvotabart Pelidotin (MICVO) in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
-
OTC Markets Group Welcomes Quartz Mountain Resources Ltd. to OTCQX
-
FactSet Reports Results for First Quarter Fiscal 2026
-
Memo Therapeutics AG’s Potravitug Granted Orphan Designation in the European Union
-
BNP Paribas Primary New Issues: Post-Stab No Stab Notice: ZENITA (Maticmind SPA)
-
RentRedi Announces Winners of First Annual “Be Property Wise” Awards, Honoring Smart, Modern Landlords Across the U.S.
-
Parsons Awarded Position on $15 Billion U.S. Air Force Comprehensive Construction & Engineering Contract
-
Trump Media & Technology Group to Merge with TAE Technologies, a Premier Fusion Power Company, in All-Stock Transaction Valued at More Than $6 Billion
-
ProFound Therapeutics Strengthens Leadership Team with Tom Chittenden as Chief Technology Officer and Laurel Ostrom as Chief Human Resources Officer
-
NorthWest Reports Results from Two Holes at its Kwanika Property Highlighted by a High-Grade Intercept of 43 Metres Grading 1.83 % Cu, 1.28 G/T Au (3.01% CuEq) from 260 Metres
-
Trump Media & Technology Group to Merge with TAE Technologies, a Premier Fusion Power Company, in All-Stock Transaction Valued at More Than $6 Billion
